Ignacio
Matos García
Consultor Médico
Azienda Ospedaliero-Universitaria Careggi
Florencia, ItaliaAzienda Ospedaliero-Universitaria Careggi-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)
Journal of Clinical Oncology, Vol. 39, Núm. 20, pp. 2304-2312